An international team of researchers led by Michael E. Belloy, PhD, assistant professor of neurology and of psychiatry at WashU Medicine, identified key genetic targets for potential Alzheimer’s disease therapeutics development. Targeting specific genes in individuals would allow researchers to take a much more precise approach to Alzheimer’s disease prevention and treatment. Their findings were […]
Autosomal dominant Alzheimer’s disease (ADAD) is a form of genetically inherited Alzheimer’s that makes up only about 1% of Alzheimer’s disease occurrences. However, because of the extremely high rate and early age at which individuals with the gene mutations develop Alzheimer’s disease, and also because of the high heritability of the mutation, ADAD is widely […]
With an increasingly aging global population and no available preventative treatments, Alzheimer’s disease and related dementias are poised to become an even larger public health challenge. The mechanisms underlying Alzheimer’s disease are difficult to study because the disease has a long developmental period during which changes in the brain can occur years before symptoms appear. […]
WashU Medicine has been awarded nearly $800,000 by the National Artificial Intelligence Research Resource (NAIRR) Pilot program, an initiative of the National Science Foundation (NSF), and Microsoft to develop AI tools aimed at improving biomedical research efficiency, with an initial focus on Alzheimer’s disease. The grant will fund the Consortium for Biomedical Research and AI […]
On April 8, Washington University School of Medicine in St. Louis recognized investigators who received their first R01 research grants from the National Institutes of Health (NIH). Receiving an R01 grant is an important milestone for scientists who are establishing their careers as independent researchers. Bhooma R. Aravamuthan, MD, DPhil, FAAN, FCNS, assistant professor of […]
A new case report published by David B. Clifford, MD, and colleagues detailed the anti-amyloid therapy treatment course of a patient who developed Alzheimer’s disease concurrently with a pre-existing HIV diagnosis. The patient, who was diagnosed with HIV in 2005, began showing signs of cognitive decline in 2015 and received a clinical diagnosis of Alzheimer’s […]
Acute provoked neonatal seizures (also known as acute symptomatic neonatal seizures) can occur in newborns whose brains are injured by a range of causes from stroke and bleeding in the brain to central nervous system infections. While the seizures themselves are scary enough for the families, the story continues after the neonates are treated for […]
The Department of Neurology at WashU Medicine is proud to announce that it has been ranked No. 2 in NIH funding among all neurology departments across the U.S. This prestigious ranking reflects the exceptional dedication and groundbreaking work of our faculty, staff and trainees. Department leadership would like to extend their heartfelt gratitude to all […]
Jin-Moo Lee, MD, PhD, head of the WashU Medicine Department of Neurology, and Eric Leuthardt, MD, MBA, vice chair of innovation in the Department of Neurosurgery, have been selected as recipients of the prestigious Falk Catalyst Award. Each year, select institutions are invited to submit up to two applications to the Dr. Ralph and Marian […]
This designation recognizes Miranda Orr, PhD, associate professor of Neurology, and her team as global leaders in spatial biology, providing access to pre-commercial technologies and close partnership with Bruker Spatial Biology to advance the next generation of discovery.